Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

2 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

3(50.0%)

Phase 4

2(33.3%)

Phase 2

1(16.7%)

6Total

N/A(3)

Phase 4(2)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT06895746Active Not Recruiting

Multi-omics Study in Citrin Deficiency

Role: collaborator

NCT06014801Phase 2Recruiting

Low-intensity Versus Medium-intensity Continuous Kidney Replacement Therapy for Critically Ill Patients

Role: lead

NCT01895517Phase 4Completed

CervIcal Cancer Screening Trial by Randomization of HPV Testing Intervention for Upcoming Screening （CITRUS Study）

Role: collaborator

NCT05851482Not ApplicableCompleted

Validation of HRM Score for the GERD Diagnosis

Role: collaborator

NCT04813029Not ApplicableUnknown

Thresholds of Straight Leg Raise Maneuver During High-Resolution-Manometry

Role: collaborator

NCT00898326Completed

PSA Levels and Biopsy Samples After Implant Radiation and Hormone Therapy in Patients With Stage I or Stage II Prostate Cancer

Role: collaborator

NCT00348231Not ApplicableUnknown

Jikei Optimal Insulin Therapy in Type 2 Diabetes

Role: lead

NCT00133328Phase 4Unknown

A Morbidity-Mortality and Remodeling Study With Valsartan

Role: lead

All 8 trials loaded